Mannosylated Thiolated Paromomycin-Loaded PLGA Nanoparticles for The Oral Therapy of Visceral Leishmaniasis
Authors:
- 28 January 2019
- journal article
- research article
- Published by Taylor & Francis in Nanomedicine
- Vol. 14 (4) , 387-406
Abstract
The present study evaluates the efficacy of paromomycin (PM)-loaded mannosylated thiomeric nanoparticles for the targeted delivery to pathological organs for the oral therapy of visceral leishmaniasis. Mannosylated thiolated chitosan (MTC)-coated PM-loaded PLGA nanoparticles (MTC-PLGA-PM) were synthesized and evaluated for morphology, drug release, permeation enhancing and antileishmanial potential. MTC-PLGA-PM were spherical in shape with a size of 391.24 ± 6.91 nm and an encapsulation efficiency of 67.16 ± 14%. Ex vivo permeation indicated 12.73-fold higher permeation of PM with MTC-PLGA-PM against the free PM. Flow cytometry indicated enhanced macrophage uptake and parasite killing in Leishmania donovani infected macrophage model. In vitro antileishmanial activity indicated 36-fold lower IC50 for MTC-PLGA-PM as compared with PM. The in vivo studies indicated 3.6-fold reduced parasitic burden in the L. donovani infected BALB/c mice model. The results encouraged the concept of MTC-PLGA-PM nanoparticles as promising strategy for visceral leishmaniasis.Keywords
This publication has 36 references indexed in Scilit:
- Chitosan-Modified PLGA Nanoparticles with Versatile Surface for Improved Drug DeliveryAAPS PharmSciTech, 2013
- Chitosan-coated PLGA nanoparticles: A sustained drug release strategy for cell culturesColloids and Surfaces B: Biointerfaces, 2013
- Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug deliveryNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated ParasitesJournal of Tropical Medicine, 2011
- Fabrication, characterization and in vitro drug release behavior of electrospun PLGA/chitosan nanofibrous scaffoldMaterials Chemistry and Physics, 2011
- Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: anin vitroevaluationJournal of Drug Targeting, 2010
- Cytokines and Their STATs in Cutaneous and Visceral LeishmaniasisJournal of Biomedicine and Biotechnology, 2010
- Migratory Dermal Dendritic Cells Act as Rapid Sensors of Protozoan ParasitesPLOS Pathogens, 2008
- Paromomycin in the treatment of leishmaniasisExpert Opinion on Investigational Drugs, 2008
- Drug Resistance in LeishmaniasisClinical Microbiology Reviews, 2006